Qiagen (QGEN) Competitors

argenx (NASDAQ:ARGX) and Qiagen (NYSE:QGEN) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

Do insiders & institutionals have more ownership in ARGX or QGEN?

60.3% of argenx shares are held by institutional investors. Comparatively, 70.0% of Qiagen shares are held by institutional investors. 2.4% of argenx shares are held by company insiders. Comparatively, 9.0% of Qiagen shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Does the MarketBeat Community favor ARGX or QGEN?

argenx received 407 more outperform votes than Qiagen when rated by MarketBeat users. Likewise, 67.35% of users gave argenx an outperform vote while only 60.14% of users gave Qiagen an outperform vote.

Company	Underperform	Outperform
argenx	Outperform Votes 656 67.35%	Underperform Votes 318 32.65%
Qiagen	Outperform Votes 249 60.14%	Underperform Votes 165 39.86%

Does the media prefer ARGX or QGEN?

In the previous week, argenx had 29 more articles in the media than Qiagen. MarketBeat recorded 38 mentions for argenx and 9 mentions for Qiagen. argenx's average media sentiment score of 0.96 beat Qiagen's score of 0.32 indicating that argenx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
argenx	19 Very Positive mention(s)	3 Positive mention(s)	12 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Qiagen	1 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Do analysts rate ARGX or QGEN?

argenx currently has a consensus target price of $690.33, indicating a potential upside of 13.84%. Qiagen has a consensus target price of $47.71, indicating a potential upside of 12.79%. Given argenx's stronger consensus rating and higher possible upside, equities analysts plainly believe argenx is more favorable than Qiagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
argenx	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.91
Qiagen	0 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.27

Which has more risk & volatility, ARGX or QGEN?

argenx has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, Qiagen has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500.

Is ARGX or QGEN more profitable?

Qiagen has a net margin of 4.23% compared to argenx's net margin of -2.11%. Qiagen's return on equity of 13.92% beat argenx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
argenx	-2.11%	-1.45%	-1.29%
Qiagen	4.23%	13.92%	8.40%

Which has better earnings & valuation, ARGX or QGEN?

Qiagen has lower revenue, but higher earnings than argenx. argenx is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
argenx	$2.19B	16.82	-$295.05M	$12.59	48.16
Qiagen	$1.98B	4.75	$83.59M	$0.36	117.50

Summary

argenx beats Qiagen on 11 of the 19 factors compared between the two stocks.